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D
espite meticulous research for the etiology of ischemic stroke, 25% to 30% of strokes remain unexplained and are consequently labelled cryptogenic (1, 2) . Occult atrial fibrillation (AF) is thought to be partly responsible for this phenomenon (3) (4) (5) (6) (7) (8) (9) . However, paroxysmal AF often goes undetected as a result of the heterogeneous presentation with no symptoms, a short duration, and episodic runs (10) . This issue has prompted new strategies to detect incident AF, especially through prolonged electrocardiogram (ECG) monitoring (3) (4) (5) (6) (7) (8) (9) . In recent years increased atrial ectopy (AE) has been shown to be associated with a higher risk of AF (11) (12) (13) (14) (15) . Some studies have reported an association with stroke as well, but the increased risk is thought to be secondary to subsequent AF (11, 12) .
The risk of stroke in persons with increased AE is unknown, and it is also not known whether these persons will present with clinical AF before having a stroke. This study investigated the independent association between increased AE and ischemic stroke.
We hypothesized that excessive supraventricular ectopic activity (ESVEA) independently increases the risk of ischemic stroke, comparable to AF. FOLLOW-UP. Events of stroke, incident AF, and death were retrieved from the national central patient registry and from discharge letters and were validated by reviewing patients' files. The diagnosis of stroke was made on the basis of clinical findings with a confirmed diagnosis by computed tomography or magnetic resonance imaging. All nonischemic strokes were excluded in the analysis for this paper. The diagnosis of incident AF was verified with documentation in the form of ECG, telemetry, or both, from patient records.
All medications were registered at baseline, and no participants were receiving treatment with anticoagulants. Endpoints included were stroke and a combined endpoint of all-cause mortality or first event of stroke.
ETHICS. All participants provided written informed consent. The regional ethical committee of Copenhagen and Frederiksberg approved the study. The study is in compliance with the Helsinki Declaration. Table 1 . Subjects who had a stroke were likely to be older, smokers, with higher blood pressure, a higher CHA 2 DS 2 -VASc (congestive heart failure, hypertension, age 75 years or older, diabetes mellitus, previous stroke or transient ischemic attack, vascular disease, age 65 to 74 years, female) score, and higher N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels, and they were more prone to be taking antithrombotic medication. Ninety-nine subjects were classified as having ESVEA; 70 subjects had >30 PACs/h daily, and 42 had runs of PACs with a length greater than $20 PACs. Thirteen subjects had both irregularities. Study subjects with ESVEA at baseline shared many of the same baseline risk factors as subjects who later developed ischemic stroke. In multivariate Cox models with censoring at time of AF and after adjustment for relevant baseline risk factors, ESVEA was associated with stroke and the combined endpoint of death or stroke ( Table 2) .
ESVEA remained associated with stroke in fully adjusted models when modeling AF as a time-varying exposure; however, the combined endpoint of stroke and death became borderline significant ( Table 3) . In 
ESTIMATED RISK OF STROKE ASSOCIATED WITH
ESVEA. We calculated the absolute risk of stroke according to the subjects' CHA 2 DS 2 -VASc score at baseline. A stepwise increase in the rates of stroke was observed with increasing score, and a significantly higher risk was seen in the patients with ESVEA, as illustrated in Figure 1 Values are hazard ratio (95% confidence interval). *Model 1: adjusted for age and sex. †Model 2: adjusted for additional stroke risk factors (age, sex, smoking, total cholesterol, diabetes, body mass index, and systolic blood pressure).
ESVEA ¼ excessive supraventricular ectopic activity. Larsen et al. (27) showed that frequent PAC (>70/24 h) represents a risk factor, independent of traditional risk factors, for paroxysmal AF (odds ratio: 6.6; 95% CI: 1.6 to 28.2) in patients with recently diagnosed ischemic stroke.
Another possibility could be that increased AE is a marker of more severe hypertension, diabetes, physical inactivity, or lipid metabolism abnormality (28), thus signifying an increased vascular risk profile and an increased probability of stroke in these subjects. In STUDY LIMITATIONS. All causation between PAC and ischemic stroke has not been documented.
Subjects with manifest or previous heart disease were excluded from this study, and we cannot dismiss the possibility that ESVEA is an epiphenomenon of undetected heart diseases, which increase the risk of stroke independently of the ectopic activity.
Although we adjust for several known covariates associated with ischemic stroke in the regression 
Length of Runs of PACs
A nonlinear association between number and runs of premature atrial contractions (PACs) with stroke was observed in these patients. In regression analysis using PACs and runs of PACs as continuous variables, we could not establish a "dose-response" association. We previously reported linear associations between PACs or runs of PACs and AF (11), but it seems that PACs and runs must be more extreme to constitute a risk for stroke. However, study subjects in the top decile carried a worse prognosis in both hourly PACs and runs of PACs. Although the definition of ESVEA was made on the basis of previously published reports, this arbitrarily defined cutoff point needs to prove its value in other populations.
CONCLUSIONS
In this middle-aged and older population, ESVEA was associated with an increased risk of ischemic stroke beyond manifest AF. Stroke was more often the first clinical presentation, rather than incident AF. ESVEA is a clinically stable and consistent finding that seems to confer a stroke risk comparable to that of AF. Excessive atrial ectopy and short atrial runs are associated with an increased risk of ischemic stroke beyond atrial fibrillation. However, the exact mechanism is not known and may be caused by undiscovered incident atrial fibrillation or an increased vascular risk profile.
CHA 2 DS 2 -VASc ¼ congestive heart failure, hypertension, age 75 years or older, diabetes mellitus, previous stroke or transient ischemic attack, vascular disease, age 65 to 74 years, female.
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